secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001213900-23-031058
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 2.01, 3.02, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avra Medical Robotics completes merger with CardioVentures, becomes SS Innovations International
--------------------------------------------------------------------------------

- Merger closed April 14, 2023; CardioVentures shareholders received ~135.8M shares (95% of post-Merger common stock) plus Series A Preferred with 51% voting control.
- Company renamed SS Innovations International, Inc.; implemented one-for-ten reverse stock split effective April 17, 2023.
- Dr. Sudhir Srivastava becomes Chairman and CEO; other management changes: Cohen becomes COO–Americas, Vishwajyoti P. Srivastava President/COO South Asia, Anup Sethi CFO.
- Dr. Frederic Moll received 3,818,028 post-Merger shares for $3M interim financing.
- Company focuses on SSI-India's 'SSI Mantra' surgical robotic system; intellectual property assigned to SSII subsidiary with 3% royalty on net revenues.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023031058/0001213900-23-031058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023031058/ea177122-8k_ssinnov.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-031058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer